CASP3 and breast carcinoma: It has been reported that vorinostat overcame apoptosis-inducing ligand Apo2L/TRAIL resistance via regulation of Bax, DR5, caspase-3, caspase-8, caspase-9 and PARP cleavage in human MDA-MB-231 breast cancer cells (35).